{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:09:28Z","timestamp":1792444168966,"version":"4.5.0"},"reference-count":58,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2020,12,1]]},"DOI":"10.1080\/14740338.2020.1832990","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T14:49:41Z","timestamp":1602859781000},"page":"1529-1538","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":73,"title":["A safety evaluation of aripiprazole in the treatment of schizophrenia"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3373-2438","authenticated-orcid":false,"given":"Adrian","family":"Preda","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Human Behavior, UC Irvine Medical Center, Orange, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan B.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Human Behavior, UC Irvine Medical Center, Orange, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,10,16]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp116"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp115"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbp130"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1016\/0920-9964(88)90034-5"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61764-X"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2010.05.025"},{"key":"cit0007","first-page":"2635","volume":"11","author":"Di Sciascio G","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"cit0008","unstructured":"ABILIFY (aripiprazole) tablets, ABILIFY DISCMELT (aripiprazole) orally disintegrating tablets, ABILIFY (aripiprazole) oral solution, ABILIFY (aripiprazole) injection for intramuscular use only; Otsuka Pharmaceutical Company. 2014."},{"key":"cit0009","unstructured":"Abilify 7.5 mg\/ml solution for injection (intramuscular) - summary of product characteristics (SmPC)."},{"key":"cit0010","unstructured":"Abilify Package Insert; Otsuka Pharmaceutical Company. 2020."},{"key":"cit0011","unstructured":"Abilify maintena package insert; Otsuka Pharmaceutical Company. 2020."},{"key":"cit0012","unstructured":"Abilify aristada package insert; Alkermes, Inc. 2019."},{"key":"cit0013","unstructured":"ABILIFY MAINTENA; European Medicines Agency."},{"key":"cit0014","unstructured":"Application number 207533orig1s000 summary review; center for drug evaluation and research. 2015."},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1517\/14740330902835493"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2010.01.021"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.2016.1121809"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-019-00801-9"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0848-4"},{"key":"cit0020","unstructured":"Aristada initio package insert; Alkermes, Inc. 2018."},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n1101"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n1201"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(04)90066-5"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(03)00087-X"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09r05060gre"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004269870"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003261901"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2013.06.041"},{"key":"cit0029","unstructured":"Abilify: European Medicines Agency. [Cited 2020 Aug 14]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/abilify"},{"issue":"1","key":"cit0030","first-page":"S186","volume":"5","author":"Lieberman J","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145703003651"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0910"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2010.12.011"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0505"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145710000490"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14m09168"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07530"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.113.134213"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2014.12.013"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.14m09741"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.15.1934"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(03)00050-1"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12902"},{"key":"cit0044","unstructured":"Food U, Administration D. FDA drug safety communication: FDA warns about new impulse-control problems associated with mental health drug aripiprazole (Abilify, Abilify Maintena, Aristada) 2016. [cited 2020 Aug 3 Aug 16]. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-new-impulse-control-problems-associated-mental-health"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000634"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000194"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60733-3"},{"issue":"1","key":"cit0048","first-page":"CD006569","volume":"2","author":"Khanna P","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"cit0049","unstructured":"Aripiprazole prolonged release suspension for injection (abilify maintena) (300 mg and 400 mg vial). CADTH Common Drug Reviews. Ottawa (ON). 2017."},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0216-9"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2015.07.007"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852918001104"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.05.011"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2017.1379412"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.15032su1"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.12r08167"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852913001016"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.10081224"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2020.1832990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T17:31:47Z","timestamp":1644946307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2020.1832990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,16]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"alternative-id":["10.1080\/14740338.2020.1832990"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2020.1832990","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-05-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}